Clinical trial
Circadian Amplification in Diabetic Retinopathy
NCT06183476 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Circadian Amplification in Diabetic Retinopathy
- Lead sponsor
- University of Illinois at Chicago
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 20, 2024
- Completion date
- January 10, 2025
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.